Boehringer Ingelheim (Canada) Ltd collaborated with IBM Canada in order to explore the blockchain technology usage into clinical trials. On February 12, 2019, they have announced about their collaboration at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida. The main purpose of this collaboration is not only to explore and test the blockchain but also […]
The post Blockchain Technology: Its Exploration And Contribution Into Clinical Trials appeared first on OWLT Market.
from OWLT Market http://bit.ly/2N1EMzO
via IFTTThttp://bit.ly/2ScyW0h
No comments:
Post a Comment